(Bloomberg) -- Not even two days after Novo Nordisk A/S pinned its comeback hopes on a new weight-loss pill that’s off to a strong start, a knock-off version is already on the market that the Danish ...

(Bloomberg) -- In what’s turning out to be a great quarter for corporate earnings growth, company executives and investors alike are focused on something else entirely: the threat from artificial ...